5-88883337-A-AAGGAGG
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The ENST00000437473.6(MEF2C):c.-528_-523dupCCTCCT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 150,194 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00029 ( 0 hom., cov: 27)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MEF2C
ENST00000437473.6 5_prime_UTR
ENST00000437473.6 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.154
Genes affected
MEF2C (HGNC:6996): (myocyte enhancer factor 2C) This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe cognitive disability, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000293 (44/150194) while in subpopulation EAS AF= 0.00593 (30/5062). AF 95% confidence interval is 0.00427. There are 0 homozygotes in gnomad4. There are 24 alleles in male gnomad4 subpopulation. Median coverage is 27. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 44 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEF2C | XM_047417217.1 | c.-528_-523dupCCTCCT | 5_prime_UTR_variant | 3/13 | XP_047273173.1 | |||
MEF2C | XM_047417181.1 | c.-528_-523dupCCTCCT | 5_prime_UTR_variant | 3/13 | XP_047273137.1 | |||
MEF2C | XM_047417182.1 | c.-531_-526dupCCTCCT | 5_prime_UTR_variant | 3/13 | XP_047273138.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEF2C | ENST00000437473.6 | c.-528_-523dupCCTCCT | 5_prime_UTR_variant | 1/11 | 1 | ENSP00000396219.2 | ||||
MEF2C | ENST00000340208.9 | c.-143+4159_-143+4164dupCCTCCT | intron_variant | 1 | ENSP00000340874.5 | |||||
MEF2C | ENST00000424173.6 | c.-143+4159_-143+4164dupCCTCCT | intron_variant | 1 | ENSP00000389610.2 |
Frequencies
GnomAD3 genomes AF: 0.000293 AC: 44AN: 150096Hom.: 0 Cov.: 27
GnomAD3 genomes
AF:
AC:
44
AN:
150096
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1428Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 916
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1428
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
916
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000293 AC: 44AN: 150194Hom.: 0 Cov.: 27 AF XY: 0.000327 AC XY: 24AN XY: 73406
GnomAD4 genome
AF:
AC:
44
AN:
150194
Hom.:
Cov.:
27
AF XY:
AC XY:
24
AN XY:
73406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual Disability, Stereotypic Movements, Epilepsy, and/or Cerebral Malformations Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at